IL221706A - Methods and Preparations for the Treatment or Prevention of Symptoms of Hormone Changes - Google Patents

Methods and Preparations for the Treatment or Prevention of Symptoms of Hormone Changes

Info

Publication number
IL221706A
IL221706A IL221706A IL22170612A IL221706A IL 221706 A IL221706 A IL 221706A IL 221706 A IL221706 A IL 221706A IL 22170612 A IL22170612 A IL 22170612A IL 221706 A IL221706 A IL 221706A
Authority
IL
Israel
Prior art keywords
compositions
treating
preventing symptoms
hormonal variations
hormonal
Prior art date
Application number
IL221706A
Other languages
English (en)
Hebrew (he)
Original Assignee
Fervent Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fervent Pharmaceuticals Llc filed Critical Fervent Pharmaceuticals Llc
Publication of IL221706A publication Critical patent/IL221706A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL221706A 2010-03-02 2012-08-30 Methods and Preparations for the Treatment or Prevention of Symptoms of Hormone Changes IL221706A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30963810P 2010-03-02 2010-03-02
PCT/US2011/026650 WO2011109367A2 (en) 2010-03-02 2011-03-01 Methods and compositions for treating or preventing symptoms of hormonal variations

Publications (1)

Publication Number Publication Date
IL221706A true IL221706A (en) 2017-08-31

Family

ID=44531862

Family Applications (2)

Application Number Title Priority Date Filing Date
IL221706A IL221706A (en) 2010-03-02 2012-08-30 Methods and Preparations for the Treatment or Prevention of Symptoms of Hormone Changes
IL253853A IL253853B (en) 2010-03-02 2017-08-06 Dextromorphan or dextrorphan for use in the treatment of symptoms of hormonal changes that cause hot flashes and night sweats

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL253853A IL253853B (en) 2010-03-02 2017-08-06 Dextromorphan or dextrorphan for use in the treatment of symptoms of hormonal changes that cause hot flashes and night sweats

Country Status (12)

Country Link
US (1) US20110218213A1 (enExample)
EP (1) EP2542241B1 (enExample)
JP (1) JP5839362B2 (enExample)
CN (1) CN102858343B (enExample)
AU (3) AU2011223807B2 (enExample)
BR (1) BR112012022052B1 (enExample)
CA (1) CA2828041C (enExample)
EA (1) EA027350B1 (enExample)
ES (1) ES2574210T3 (enExample)
IL (2) IL221706A (enExample)
PL (1) PL2542241T3 (enExample)
WO (1) WO2011109367A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9616123B1 (en) * 2012-03-05 2017-04-11 Robert L. Knobler Method and compound for treatment of menopausal symptoms
JP6038416B1 (ja) * 2015-04-07 2016-12-07 株式会社明治 火照り抑制剤
WO2019094596A1 (en) 2017-11-09 2019-05-16 The Trustees Of Columbia University In The City Of New York Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders
US11491120B2 (en) 2017-11-09 2022-11-08 The Trustees Of Columbia University In The City Of New York Pharmacological prophylactics against stress-induced affective disorders in females
EP3958862A4 (en) * 2019-04-22 2023-01-25 Robert L. Knobler NON-HORMONIC HOT FLASH TREATMENT
US20220401366A1 (en) * 2019-11-15 2022-12-22 Consegna Pharma, Inc. Long acting nmda antagonists

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
EP2283821A1 (en) * 1993-11-19 2011-02-16 Alkermes, Inc. Preparation of biodegradable microparticles containing a biologically active agent
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
NZ517044A (en) * 1999-07-22 2004-02-27 Univ Rochester Gamma-aminobutyric acid analogues, e.g. gabapentin and pregabalin, to treat symptoms of hormonal variation, including hot flushes, nausea, emesis and fever
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6569471B2 (en) * 2000-09-01 2003-05-27 Natumin Pharma Ab Method for the treatment of symptoms related to normal hormonal variations in women
US20050129783A1 (en) * 2001-04-19 2005-06-16 Mccleary Edward L. Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
WO2003037334A1 (en) * 2001-10-31 2003-05-08 Merck & Co., Inc. Method for treating or preventing symptoms of hormonal variation including hot flashes
EP1534258A2 (en) * 2002-08-15 2005-06-01 Wyeth AGONISM OF THE 5HT 2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION
HUP0303313A2 (hu) * 2003-10-09 2005-07-28 Richter Gedeon Vegyészeti Gyár Rt. Transzdermális gyógyszerkészítmények
US7855195B2 (en) * 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1753460A2 (en) * 2004-05-11 2007-02-21 Pfizer Products Inc. Combination of atypical antipsychotics and 5-ht1b receptor antagonists
CA2569411A1 (en) * 2004-06-04 2005-12-22 Mood Management Sciences, Llc Methods and compositions for treating mood disorder
EP1827450A4 (en) * 2004-11-17 2009-04-22 Cypress Bioscience Inc METHOD FOR REDUCING THE SIDE EFFECTS OF TREATMENT WITH MIRTAZAPINE
MX2008000248A (es) * 2005-07-06 2008-03-19 Sepracor Inc Combinaciones de eszopiclona y un antidepresivo y metodos de tratamiento contra la menopausia y trastornos del estado de animo, la ansiedad y trastornos cognitivos.
JP5528705B2 (ja) * 2005-12-13 2014-06-25 トリニティ ラボラトリーズ インコーポレイテッド ヒトにおける早漏を治療するための方法
JP2009525343A (ja) * 2006-02-03 2009-07-09 アバニール・ファーマシューティカルズ 鬱病、不安および神経変性疾患を治療するためのデキストロメトルファンおよびキニジンを含む薬剤組成物
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
ES2423485T3 (es) * 2007-03-19 2013-09-20 Acadia Pharmaceuticals Inc. Asociaciones de agonistas y antagonistas inversos 5-HT2A con antipsicóticos
CN102223893B (zh) * 2008-07-22 2014-07-16 曼诺吉尼克斯公司 治疗与绝经、激素改变和关节炎相关的症状的组合物和方法

Also Published As

Publication number Publication date
ES2574210T3 (es) 2016-06-15
BR112012022052A2 (pt) 2020-07-07
WO2011109367A4 (en) 2012-02-23
AU2016213776B2 (en) 2018-04-12
IL253853B (en) 2019-05-30
CA2828041A1 (en) 2011-09-09
EA201290851A1 (ru) 2013-04-30
WO2011109367A3 (en) 2011-12-29
JP5839362B2 (ja) 2016-01-06
CN102858343B (zh) 2015-11-25
EP2542241A4 (en) 2013-11-06
AU2016213776A1 (en) 2016-09-01
AU2011223807B2 (en) 2016-05-12
AU2011223807A1 (en) 2012-10-18
CN102858343A (zh) 2013-01-02
WO2011109367A2 (en) 2011-09-09
EA027350B1 (ru) 2017-07-31
BR112012022052B1 (pt) 2021-06-29
EP2542241A2 (en) 2013-01-09
AU2018205147A1 (en) 2018-08-02
PL2542241T3 (pl) 2016-12-30
EP2542241B1 (en) 2016-04-27
IL253853A0 (en) 2017-09-28
JP2013521297A (ja) 2013-06-10
US20110218213A1 (en) 2011-09-08
CA2828041C (en) 2018-04-17

Similar Documents

Publication Publication Date Title
EP2655334A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
EP2771030A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROTEINOPATHIES
EP2523944A4 (en) COMPOUNDS AND COMPOSITIONS FOR IMPROVING COGNITION, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT
ZA201302625B (en) Methods and compositions for treating hemophilia b
SG10201509279QA (en) Compositions and methods for the prevention and treatment of cancer
IL239918A0 (en) Preparations for the treatment of colitis
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
IL215592A0 (en) Compositions and methods for the treatment of inflammation
ZA201404187B (en) Compositions and methods for treating dental conditions
IL226101A0 (en) Preparations and methods for the treatment of myelofibrosis
IL225488A0 (en) Compounds and methods for the treatment of hematological malignancies
IL253853A0 (en) Methods and preparations for the treatment or prevention of symptoms of hormonal changes
IL214455A0 (en) Methods and compositions for treatment of neovascularization
IL216993A0 (en) Compositions and methods for treatment of multiple sclerosis
EP2590674A4 (en) COMPOSITIONS AND METHODS FOR INFLUENZA TREATMENT
GB201013975D0 (en) Method of treating desease
ZA201303222B (en) Composition and method for treating skin conditions
EP2507373A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING VEGF
IL225483A0 (en) The compositions and methods for the treatment of neoplasia
ZA201303996B (en) Compositions and methods for treating amyloid plaque associated symptoms
WO2011137427A9 (en) Compositions and methods for treating pulmonary conditions
GB201013701D0 (en) A method of treating testosterone deficiency and pharmaceutical compositions for use in such a method
SI2731616T1 (sl) Postopek preventive in zdravljenja sepse
ZA201305497B (en) Methods and compositions for preventing and treating osteoarthritis
IL221809A (en) Herbal preparation for the prevention and / or treatment of anxiety and related conditions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed